Are Mutation Carrier Patients Different from Non-Carrier Patients? Genetic, Pathology, and US Features of Patients with Breast Cancer

SIMPLE SUMMARY: Up to 30% of breast cancer patients are carriers of pathogenic mutations in breast cancer susceptibility genes. Except for BRCA1/2 genes that account only for 22–30% of hereditary breast cancer, less is known about the remaining genes that are prone to breast cancer. Our aim was to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pintican, Roxana Maria, Chiorean, Angelica, Duma, Magdalena, Feier, Diana, Szep, Madalina, Eniu, Dan, Goidescu, Iulian, Dudea, Sorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179636/
https://www.ncbi.nlm.nih.gov/pubmed/35681739
http://dx.doi.org/10.3390/cancers14112759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179636/
https://www.ncbi.nlm.nih.gov/pubmed/35681739
http://dx.doi.org/10.3390/cancers14112759

Ejemplares similares